Publication: Drug repurposing of N-acetyl cysteine as antiviral against dengue virus infection
Issued Date
2019-06-01
Resource Type
ISSN
18729096
01663542
01663542
Other identifier(s)
2-s2.0-85063692516
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Antiviral Research. Vol.166, (2019), 42-55
Suggested Citation
Gopinathan Pillai Sreekanth, Jutatip Panaampon, Aroonroong Suttitheptumrong, Aporn Chuncharunee, Jintana Bootkunha, Pa thai Yenchitsomanus, Thawornchai Limjindaporn Drug repurposing of N-acetyl cysteine as antiviral against dengue virus infection. Antiviral Research. Vol.166, (2019), 42-55. doi:10.1016/j.antiviral.2019.03.011 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/51057
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Drug repurposing of N-acetyl cysteine as antiviral against dengue virus infection
Other Contributor(s)
Abstract
© 2019 Elsevier B.V. Liver injury is one of the hallmark features of severe dengue virus (DENV) infection since DENV can replicate in the liver and induce hepatocytes to undergo apoptosis. N-acetyl cysteine (NAC), which is a clinically-used drug for treating acetaminophen toxicity, was found to benefit patients with DENV-induced liver injury; however, its mechanism of action remains unclear. Accordingly, our aim was to repurpose NAC in the preclinical studies to investigate its mechanism of action. Time of addition experiments in HepG2 cells elucidated effectiveness of NAC to reduce infectious virion at pre-, during- and post infection. In DENV-infected mice, NAC improved DENV-associated clinical manifestations, including leucopenia and thrombocytopenia, and reduced liver injury and hepatocyte apoptosis. Interestingly, we discovered that NAC significantly reduced DENV production in HepG2 cells and in liver of DENV-infected mice by induction of antiviral responses via interferon signaling. NAC treatment in DENV-infected mice helped to maintain antioxidant enzymes and redox balance in the liver. Therefore, NAC reduces DENV production and oxidative damage to ameliorate DENV-induced liver injury. Taken together, these findings suggest the novel therapeutic potential of NAC in DENV-induced liver injury and recommend evaluating its efficacy and safety in humans with DENV-induced liver injury.